Work

Clinical Genomic Analyses Demonstrate t(11;14) Multiple Myeloma Retains B-Cell Biology and Distinct Mitochondrial Metabolism That Convey Increased Sensitivity to BCL-2 Inhibition By Venetoclax

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-160195

Authors: David Sharon, Fengjiao Dunbar, Paul Jung, Xifeng Wang, Xiaotong Li, Christine Mantis, Orlando F. Bueno, Cyrille Touzeau, Philippe Moreau, Simon J Harrison, Luciano J. Costa, Jonathan L. Kaufman, Nizar J. Bahlis, Shaji K Kumar, Jeremy A. Ross, P.K. Epling-Burnette

Institutions: AbbVie (United States), Inserm, Centre Hospitalier Universitaire de Nantes, Université de Nantes, Nantes Université, The Royal Melbourne Hospital, Peter MacCallum Cancer Centre, University of Alabama at Birmingham, Emory University, Winship Cancer Institute, University of Calgary, Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310119502

FWCI:

Cites:

Cited by:

Related to: 10